Boryung Pharm signs $15 million Kanarb export deal

Published: 2013-01-09 06:57:00

Updated: 2013-01-09 06:57:00

Local drug maker Boryung Pharmaceutical said Monday it has signed a contract with R-Pharm of Russia to export newly developed Kanarb (fimasartan) for treatment of hypertension.

This agreement will allow Dong-A to export about 15 million dollars of Kanarb as well as a royalty of $1.5 million to...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK